Novel biomarkers for cardio-renal syndrome

Electrolyte and Blood Pressure

Volumn 10, Issue 1, 2012, Pages 12-17

  Lee, Sul Ra ^a   Jeong, Kyung Hwan ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Acute kidney injury; Biomarker; Cardio renal syndrome; Heart failure

Indexed keywords

BIOLOGICAL MARKER; CYSTATIN C; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; N ACETYL BETA GLUCOSAMINIDASE; NATRIURETIC FACTOR; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TROPONIN;

CARDIORENAL SYNDROME; CHEMICAL ANALYSIS; HUMAN; REVIEW;

EID: 84885453005     PISSN: 17385997     EISSN: 20929935     Source Type: Journal    
DOI: 10.5049/EBP.2012.10.1.12     Document Type: Review

References (35)

1. Flower DR, North AC, Attwood TK: Structure and sequence relationships in the lipocalins and related proteins. Protein Sci 2:753-761, 1993 (Pubitemid 23121090)
2. Mishra J, Dent C, Tarabishi R, et al.: Neutrophil gelatinaseassociated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365:1231-1238, 2005 (Pubitemid 40469655)
3. Mishra J, Ma Q, Prada A, et al.: Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14:2534-2543, 2003 (Pubitemid 37169339)
4. Mishra J, Mori K, Ma Q, Kelly C, Barasch J, Devarajan P: Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 24:307-315, 2004 (Pubitemid 39070114)
5. Cruz DN, Fard A, Clementi A, Ronco C, Maisel A: Role of biomarkers in the diagnosis and management of cardio-renal syndromes. Semin Nephrol 32:79-92, 2012
6. Alvelos M, Pimentel R, Pinho E, et al.: Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward. Clin J Am Soc Nephrol 6:476-481, 2011
7. Shaker OG, El-Shehaby A, El-Khatib M: Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography. Angiology 61:731-736, 2010
8. Han WK, Wagener G, Zhu Y, Wang S, Lee HT: Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol 4:873-882, 2009
9. Damman K, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL: Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. Eur J Heart Fail 10:997-1000, 2008
10. Yndestad A, Landro L, Ueland T, et al.: Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur Heart J 30:1229-1236, 2009
11. Liangos O, Tighiouart H, Perianayagam MC, et al.: Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers 14:423-431, 2009
12. Malyszko J, Bachorzewska-Gajewska H, Poniatowski B, Malyszko JS, Dobrzycki S.: Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease. Ren Fail 31:910-919, 2009
13. Damman K, Van Veldhuisen DJ, Navis G, et al.: Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart (British Cardiac Society) 96:1297-1302, 2010
14. Koyner JL, Vaidya VS, Bennett MR, et al.: Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 5:2154-2165, 2010
15. Wang QP, Gu JW, Zhan XH, Li H, Luo XH.: Assessment of glomerular filtration rate by serum cystatin C in patients undergoing coronary artery bypass grafting. Ann Clin Biochem 46:495-500, 2009
16. Lassus JP, Nieminen MS, Peuhkurinen K, et al.: Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome. Eur Heart J 31:2791-2798, 2010
17. Tang WH, Van Lente F, Shrestha K, et al. Impact of myocardial function on cystatin C measurements in chronic systolic heart failure. J Card Fail 14:394-399, 2008 (Pubitemid 351749833)
18. Gibey R, Dupond JL, Alber D, Leconte des Floris R, Henry JC: Predictive value of urinary N-acetyl-beta-D-glucosaminidase (NAG), alanine-aminopeptidase (AAP) and beta-2-microglobulin (beta 2M) in evaluating nephrotoxicity of gentamicin. Clin Chim Acta 116:25-34, 1981 (Pubitemid 11060000)
19. Westhuyzen J, Endre ZH, Reece G, Reith DM, Saltissi D, Morgan TJ: Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant 18:543-551, 2003 (Pubitemid 36305660)
20. Parikh CR, Jani A, Mishra J, et al.: Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 6: 1639-1645, 2006 (Pubitemid 43945804)
21. Liang XL, Liu SX, Chen YH, et al.: Combination of urinary kidney injury molecule-1 and interleukin-18 as early biomarker for the diagnosis and progressive assessment of acute kidney injury following cardiopulmonary bypass surgery: a prospective nested case-control study. Biomarkers 15:332-339, 2010
22. McIlroy DR, Wagener G, Lee HT: Biomarkers of acute kidney injury: an evolving domain. Anesthesiology 112: 998-1004, 2010
23. DeFilippi CR, Fink JC, Nass CM, Chen H, Christenson R: N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis. Am J Kidney Dis 46:35-44, 2005 (Pubitemid 40848431)
24. Goto T, Takase H, Toriyama T, et al.: Increased circulating levels of natriuretic peptides predict future cardiac event in patients with chronic hemodialysis. Nephron 92:610-615, 2002
25. Sommerer C, Beimler J, Schwenger V, et al.: Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest 37:350-356, 2007 (Pubitemid 46653136)
26. Luchner A, Hengstenberg C, Lowel H, Riegger GA, Schunkert H, Holmer S: Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 46:118-123, 2005 (Pubitemid 40946501)
27. Apple FS, Murakami MM, Pearce LA, Herzog CA.: Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive pro-tein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 50:2279-2285, 2004 (Pubitemid 39552162)
28. Carr SJ, Bavanandan S, Fentum B, Ng L Prognostic potential of brain natriuretic peptide (BNP) in predialysis chronic kidney disease patients. Clin Sci (Lond) 109:75-82, 2005 (Pubitemid 40943036)
29. Satyan S, Light RP, Agarwal R. Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. Am J Kidney Dis 50: 1009-1019, 2007 (Pubitemid 350122814)
30. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355:1126-1130, 2000 (Pubitemid 30172933)
31. Jourdain P, Jondeau G, Funck F, et al.: Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 49:1733-1739, 2007 (Pubitemid 46589928)
32. Apple FS, Murakami MM, Pearce LA, Herzog CA: Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 106:2941-2945, 2002 (Pubitemid 35424746)
33. Aviles RJ, Askari AT, Lindahl B, et al.: Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 346:2047-2052, 2002 (Pubitemid 34680596)
34. Mallamaci F, Zoccali C, Parlongo S, et al.: Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 40:68-75, 2002 (Pubitemid 34701213)
35. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 45:S1-153, 2005